These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10603750)

  • 1. [Positron-emission tomography of liver tumors].
    Keiding S; Schiøtt KM; Vilstrup H; Gjedde A
    Ugeskr Laeger; 1999 Nov; 161(45):6163-5. PubMed ID: 10603750
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.
    Shiomi S; Sasaki N; Kawashima D; Jomura H; Fukuda T; Kuroki T; Koyama K; Kawabe J; Ochi H
    Clin Nucl Med; 1999 May; 24(5):370-1. PubMed ID: 10232488
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines.
    Barreiros AP; Piscaglia F; Dietrich CF
    J Hepatol; 2012 Oct; 57(4):930-2. PubMed ID: 22739095
    [No Abstract]   [Full Text] [Related]  

  • 4. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.
    Nagaoka S; Itano S; Ishibashi M; Torimura T; Baba K; Akiyoshi J; Kurogi J; Matsugaki S; Inoue K; Tajiri N; Takada A; Ando E; Kuromatsu R; Kaida H; Kurogi M; Koga H; Kumashiro R; Hayabuchi N; Kojiro M; Sata M
    Liver Int; 2006 Sep; 26(7):781-8. PubMed ID: 16911459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
    Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
    Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT--a comparative study.
    Loyer EM; Chin H; DuBrow RA; David CL; Eftekhari F; Charnsangavej C
    Radiology; 1999 Sep; 212(3):866-75. PubMed ID: 10478259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [71-year-old man with a palpable mass in the right flank].
    Moreira Vicente V; Pérez Fernández T; Retamar Mancha JA
    Rev Clin Esp; 1996 Apr; 196(4):255-6. PubMed ID: 8701066
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of color Doppler ultrasound in preoperative planning of the resection of liver tumors].
    Bunk A; Stoelben E; Köhler T; Nagel M; Seager HD
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():428-30. PubMed ID: 9574172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronously resected double primary hepatic cancer, hepatocellular carcinoma and cholangiocarcinoma.
    Fuji N; Taniguchi H; Amaike H; Oka K; Tsuchihashi Y; Urasaki K; Naito K
    J Gastroenterol Hepatol; 2005 Jun; 20(6):967-9. PubMed ID: 15946156
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis.
    Kim AY; Jeong WK
    Clin Mol Hepatol; 2016 Mar; 22(1):192-7. PubMed ID: 27044773
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver tumor as incidental ultrasound finding].
    Görtz RS; Strobel D
    MMW Fortschr Med; 2010 Jan; 152(3):41-3. PubMed ID: 20333967
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver tumor characterization--review of the literature.
    Dietrich CF; Maddalena ME; Cui XW; Schreiber-Dietrich D; Ignee A
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S3-10. PubMed ID: 22723026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multidetector computed tomography of the liver].
    Schima W; Kulinna C; Ba-Ssalamah A; Grünberger T
    Radiologe; 2005 Jan; 45(1):15-23. PubMed ID: 15609013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Kim JO; Jun DW; Jang K
    Korean J Gastroenterol; 2013 Aug; 62(2):135-9. PubMed ID: 24133714
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality imaging of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Shahbazian H; Mirza-Aghazadeh-Attari M; Borhani A; Mohseni A; Madani SP; Ansari G; Pawlik TM; Kamel IR
    J Surg Oncol; 2023 Sep; 128(4):519-530. PubMed ID: 37439096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
    Sacks A; Peller PJ; Surasi DS; Chatburn L; Mercier G; Subramaniam RM
    AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI appearance of combined hepatocellular cholangiocarcinoma.
    Billet N; Grégory J; Ronot M
    Diagn Interv Imaging; 2022 Dec; 103(12):625-626. PubMed ID: 36243674
    [No Abstract]   [Full Text] [Related]  

  • 19. CEUS and HCC: are the 2008 EFSUMB guidelines still valid or has their wash-out already started?
    Giorgio A; Calisti G; Giorgio V
    Ultraschall Med; 2011 Jun; 32(3):315-6. PubMed ID: 21667409
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of CT and MRI in malignant hepatobiliary tumors].
    Kahn T
    Zentralbl Chir; 2000; 125(7):610-5. PubMed ID: 10960971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.